Skip to content

Martin Taylor

Director at Antlia Bioscience.

Earliest Form D on file: Jun 2026

Filed Jun 5, 2026

Antlia Bioscience

Long-acting peptide therapy for chronic heart failure

Biotech, Encinitas CA

Named, Director.

$6M

sold of $20M offered

Form D

Network

At Antlia Bioscience

5 people